Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG and LFCN Block vs Caudal Block for Postoperative Analgesia in Pediatric Hip Surgeries
NCT06417268Phase 2Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Mar 2024
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Phase 2, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Time to first rescue analgesia at 24 hours. Started Mar 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06417268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06417268.